Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: Rationale and design of the DECREASE-IV study

2004-12-01

American Heart Journal , Volume 148 - Issue 6 p. 1047- 1052

Additional Metadata
Persistent URL	doi.org/10.1016/j.ahj.2004.05.046, hdl.handle.net/1765/52837
Journal	American Heart Journal
Organisation	Department of Neurology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Schouten, O., Poldermans, D., Visser, L., Kertai, M., Klein, J., van Urk, H., Simoons, M., van de Ven, L., Vermeulen, M., Bax, J., Lameris, T.& Boersma, E. (2004). Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: Rationale and design of the DECREASE-IV study. American Heart Journal, 148(6), 1047–1052.https://doi.org/10.1016/j.ahj.2004.05.046

Publication